STIGALL L. JEREMY bought CLPT
March 6, 2026 · Form 4 insider transaction
STIGALL L. JEREMY bought 17,778 shares of ClearPoint Neuro, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,778
Price
N/A
Total value
N/A
InsiderSTIGALL L. JEREMY
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 6, 2026
Filing dateMarch 10, 2026
Shares owned after94,484
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.